NCT02979613 Study to Evaluate Efficacy and Safety of Switching From TDF to TAF in Adults With Chronic Hepatitis B Who Are Virologically Suppressed Status COMPLETED Phase PHASE3
NCT02968563 Study to Evaluate the Safety and Efficacy of the Combination of Tirabrutinib and Idelalisib With and Without Obinutuzumab in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) Status COMPLETED Phase PHASE2
NCT02959138 Pharmacokinetics of Lanraplenib in Adults With Impaired Renal Function Status COMPLETED Phase PHASE1
NCT02958358 FDG Uptake and Lung Blood Flow in PAH Before and After Treatment With Ambrisentan Status WITHDRAWN Phase NA
NCT02957864 Switching From Tenofovir Disoproxil Fumarate to Abacavir or Tenofovir Alafenamide Status UNKNOWN Phase PHASE4
NCT02955602 Seladelpar (MBX-8025) in Subjects With Primary Biliary Cholangitis (PBC) Status COMPLETED Phase PHASE2
NCT02953782 Study of Magrolimab (Hu5F9-G4) in Combination With Cetuximab in Participants With Solid Tumors and Advanced Colorectal Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT02953509 Trial of Magrolimab (Hu5F9-G4) in Combination With Rituximab or Rituximab + Chemotherapy in Participants With Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma Status TERMINATED Phase PHASE1/PHASE2
NCT02951364 Harvoni in Patients With Chronic Hepatitis C Virus (HCV) Infection in Korea Status COMPLETED Phase N/A
NCT02943460 Study to Evaluate the Safety, Tolerability, and Efficacy of Cilofexor in Adults With Primary Sclerosing Cholangitis Without Cirrhosis Status COMPLETED Phase PHASE2
NCT02943447 Study to Evaluate the Safety, Tolerability, and Efficacy of Cilofexor in Adults With Primary Biliary Cholangitis Without Cirrhosis Status TERMINATED Phase PHASE2
NCT02932150 Study of Tenofovir Alafenamide (TAF) in Children and Teen Participants With Chronic Hepatitis B Virus Infection Status RECRUITING Phase PHASE2
NCT02928510 Mechanisms of Idelalisib-Associated Diarrhea in Patients With Relapsed Chronic Lymphocytic Leukemia, Indolent Non-hodgkin Lymphoma, or Small Lymphocytic Lymphoma Status TERMINATED Phase N/A
NCT02914600 Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease Status TERMINATED Phase PHASE3
NCT02914561 Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease Status COMPLETED Phase PHASE3
NCT02914535 Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT02914522 Study to Evaluate the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis Status COMPLETED Phase PHASE3
NCT02907996 Evaluate the Safety and Effectiveness of Sovaldi in Participants With Chronic Hepatitis C Virus (HCV) Infection in Korea Status COMPLETED Phase N/A
NCT02891408 Study to Evaluate the Pharmacokinetics of Firsocostat or Fenofibrate in Adults With Normal and Impaired Hepatic Function Status COMPLETED Phase PHASE1
NCT02889796 Filgotinib in Combination With Methotrexate in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate Status COMPLETED Phase PHASE3